# Viral Hepatitis

> What are the causal organisms of viral hepatitis and discuss on viral hepatitis in children. (UMM)

## Causal Organisms

1. Hepatitis A virus
1. Hepatitis B virus
1. Hepatitis C virus
1. Hepatitis D virus
1. Hepatitis E virus
1. Non A-E viral hepatitis
1. Epstein-Barr virus
1. Herpes simplex virus

## 1. Clinical Features

- **Acute phase**:
  - **Prodromal symptoms**: fatigue, anorexia, nausea, vomiting, low-grade fever
  - **Jaundice**
  - **Dark urine**
  - **Hepatomegaly**
- **Chronic phase (especially B, C)**:
  - Often asymptomatic initially
  - Can progress to chronic liver disease

## 2. Investigations

- **Serology**:
  - **Hepatitis A**: anti-HAV IgM for acute, anti-HAV IgG for past infection/immunity
  - **Hepatitis B**: HBsAg, anti-HBc IgM, HBeAg, anti-HBs (immunity marker)
  - **Hepatitis C**: anti-HCV, HCV RNA PCR for viral load
  - **Hepatitis D**: anti-HDV and HDV RNA
  - **Hepatitis E**: anti-HEV IgM, HEV RNA in blood/stool
- **Liver function tests**:
  - Elevated AST, ALT (typically higher than 10x normal in acute cases)
  - Elevated bilirubin, alkaline phosphatase
- **Imaging** (if chronic liver disease suspected): ultrasound or elastography for liver fibrosis

## 3. Complications

1. Acute hepatic failure
1. Chronic hepatitis
1. Hepatocellular carcinoma
1. Cirrhosis (with Hepatitis B, C)
1. Renal failure
1. Aplastic anaemia

## 4. Treatment

- **Hepatitis A and E**: usually self-limiting, supportive care
- **Hepatitis B**:
  - Acute: supportive; antiviral therapy if severe
  - Chronic: long-term antivirals (e.g., `tenofovir`, `entecavir`)
- **Hepatitis C**:
  - Direct-acting antivirals (DAAs), e.g., `sofosbuvir`, `ledipasvir`, with 8-12 week regimens
- **Hepatitis D**:
  - Pegylated interferon-alpha in select cases

## 5. Prevention

- **Vaccination**:
  - Hepatitis A and B vaccines available
- **Post-exposure prophylaxis**:
  - Immunoglobulin for hepatitis A exposure
  - Hepatitis B immunoglobulin and vaccine for HBV exposure
- **Public health measures**:
  - Safe injection practices, blood screening, hygiene in food handling (hepatitis A, E)

## 6. Prognosis

- **Hepatitis A and E**: favorable, with full recovery in most cases
- **Hepatitis B and C**: variable; chronic infections can lead to serious complications
- **Hepatitis D**: poor prognosis in co-infection with HBV, increased risk of fulminant hepatitis and cirrhosis
